PMID: 16531667Mar 15, 2006Paper

Clinical outcome of autologous cultivated limbal epithelium transplantation

Indian Journal of Ophthalmology
Virender S SangwanGullapalli N Rao

Abstract

To report the clinical outcome of autologous cultivated limbal epithelial transplantation. Eighty-six patients' records and their clinical photographs were reviewed for demographics, primary etiology, type of limbal transplantation, ocular surface stability, visual acuity, final outcome and possible factors affecting outcome and complications. Eighty-eight eyes of 86 patients with limbal stem cell deficiency (LSCD) underwent autologous cultivated limbal epithelium transplantation between March 2001 and May 2003, with a mean follow-up of 18.3 months. The etiology of LSCD was alkali burns in 64% patients. Sixty-one eyes had total LSCD. Thirty-two of the 88 eyes had undergone amniotic membrane transplantation and 10 eyes had previously undergone limbal transplantation with unfavorable outcome. Nineteen eyes underwent penetrating keratoplasty, of which 11 grafts survived at the final follow-up. Finally, 57 eyes (73.1%, 95% CI: 63.3-82.9) had a successful outcome with a stable ocular surface without conjunctivalization, 21 eyes (26.9%, 95%CI: 17.1-36.7) were considered failures and 10 patients were lost to follow-up. LSCD can be successfully treated by autologous cultivated limbal epithelium transplantation in majority of the cases.

Citations

Jan 24, 2009·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M PauklinD Meller
Jul 31, 2013·Journal of Materials Science. Materials in Medicine·Ana de la MataMargarita Calonge
Dec 1, 2012·Journal of Ocular Biology, Diseases, and Informatics·Anindita ChakrabortyHimadri Datta
Apr 30, 2010·The Ocular Surface·Alex J ShorttJulie T Daniels
Jun 26, 2013·Expert Reviews in Molecular Medicine·Romesh I AngunawelaJulie T Daniels
Jul 31, 2010·Nature Protocols·Indumathi MariappanGeeta K Vemuganti
Sep 20, 2011·British Medical Bulletin·Alex J ShorttJulie T Daniels
Oct 12, 2012·Clinical Ophthalmology·Pinnita PrabhasawatNattaporn Tesavibul
Jul 1, 2009·International Journal of Trichology·Rajiv SainiSugandha Sharma
Mar 5, 2014·Journal of Translational Medicine·Nadia ZakariaMarie-Jose Tassignon
Nov 5, 2011·Regenerative Medicine·Sharon L MasonCarl M Sheridan
Aug 27, 2014·Stem Cell Research & Therapy·Kamesh DhamodaranDebashish Das
Feb 20, 2013·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Johannes Menzel-SeveringUrsula Schlötzer-Schrehardt
Aug 18, 2010·The Ocular Surface·Enzo Di IorioVanessa Barbaro
Dec 10, 2015·Asia-Pacific Journal of Ophthalmology·Nadia ZakariaMarie-José Tassignon
Jan 21, 2016·Stem Cells International·Michel HaagdorensNadia Zakaria
Jun 17, 2008·Ophthalmology·Alex J ShorttJulie T Daniels
May 31, 2008·Journal of Tissue Engineering and Regenerative Medicine·Subhadra DravidaGeeta K Vemuganti
Feb 11, 2011·Journal of Cellular Biochemistry·Oliver BaylisSajjad Ahmad
Oct 17, 2012·Veterinary Ophthalmology·Eunryel NamRyohei Nishimura
May 20, 2008·American Journal of Ophthalmology·Paul A CauchiJennifer M Burr
Jan 30, 2014·Veterinary Ophthalmology·Maresuke MoritaRyohei Nishimura
Oct 26, 2010·Experimental Eye Research·S Louise AinscoughDamien G Harkin
Jul 13, 2012·Seminars in Ophthalmology·Medi EslaniSajjad Ahmad
Oct 4, 2014·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Hong He, Samuel C Yiu
Jul 22, 2008·Experimental Eye Research·D FrancisM Daniell
May 7, 2016·The Ocular Surface·Jayesh VaziraniVirender S Sangwan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.